131 related articles for article (PubMed ID: 3528209)
1. Feedback inhibition of insulin secretion is altered in cirrhosis.
Cavallo-Perin P; Bruno A; Nuccio P; Goria M; Pagano G; Lenti G
J Clin Endocrinol Metab; 1986 Oct; 63(4):1023-7. PubMed ID: 3528209
[TBL] [Abstract][Full Text] [Related]
2. Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus.
Garvey WT; Revers RR; Kolterman OG; Rubenstein AH; Olefsky JM
J Clin Endocrinol Metab; 1985 Mar; 60(3):559-68. PubMed ID: 3882736
[TBL] [Abstract][Full Text] [Related]
3. Hyperinsulinaemia and insulin resistance of cirrhosis: the importance of insulin hypersecretion.
Proietto J; Dudley FJ; Aitken P; Alford FP
Clin Endocrinol (Oxf); 1984 Dec; 21(6):657-65. PubMed ID: 6391746
[TBL] [Abstract][Full Text] [Related]
4. The metabolic clearance of insulin and the feedback inhibition of insulin secretion are altered with aging.
Fink RI; Revers RR; Kolterman OG; Olefsky JM
Diabetes; 1985 Mar; 34(3):275-80. PubMed ID: 3882495
[TBL] [Abstract][Full Text] [Related]
5. Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis.
Kruszynska YT; Home PD; McIntyre N
Hepatology; 1991 Jul; 14(1):103-11. PubMed ID: 2066059
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect.
Cavallo-Perin P; Cassader M; Bozzo C; Bruno A; Nuccio P; Dall'Omo AM; Marucci M; Pagano G
J Clin Invest; 1985 May; 75(5):1659-65. PubMed ID: 3889056
[TBL] [Abstract][Full Text] [Related]
7. Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.
Petrides AS; Groop LC; Riely CA; DeFronzo RA
J Clin Invest; 1991 Aug; 88(2):561-70. PubMed ID: 1864966
[TBL] [Abstract][Full Text] [Related]
8. Feedback inhibition of insulin and glucagon secretion by insulin is altered in abdominal obesity with normal or impaired glucose tolerance.
Cavallo-Perin P; Bruno A; Scaglione L; Gruden G; Cassader M; Pagano G
Acta Diabetol; 1993; 30(3):154-8. PubMed ID: 8111076
[TBL] [Abstract][Full Text] [Related]
9. Hyperinsulinemia in the physiologic range is not superior to short-term fasting in suppressing insulin secretion in obese men.
Pincelli AI; Brunani A; Caumo A; Scacchi M; Pasqualinotto L; Tibaldi A; Dubini A; Bonadonna S; Cavagnini F
Metabolism; 2001 Jan; 50(1):107-11. PubMed ID: 11172483
[TBL] [Abstract][Full Text] [Related]
10. Impaired feedback inhibition of insulin secretion by hyperinsulinemia in patients with insulinoma.
Hiramatsu S; Sako Y; Mimura K; Ono Y; Iwashige K; Taniguchi S; Umeda F; Nawata H
Endocr J; 1995 Feb; 42(1):39-42. PubMed ID: 7599696
[TBL] [Abstract][Full Text] [Related]
11. Insulin secretion and sensitivity in acromegaly.
Jap TS; Ho LT
Clin Physiol Biochem; 1990; 8(2):64-9. PubMed ID: 2193770
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance in human liver cirrhosis is not modified by porto-systemic surgical shunt.
Cavallo-Perin P; Bruno A; Nuccio P; Dall'omo AM; Fronda GR; Avagnina P; Molino G; Bozzo C; Pagano G
Acta Endocrinol (Copenh); 1986 Jul; 112(3):377-82. PubMed ID: 3529784
[TBL] [Abstract][Full Text] [Related]
13. Lack of suppression of insulin secretion by hyperinsulinemia in a patient with an insulinoma.
Cohen P; Barzilai N; Bar-Ilan R; Yassin K; Karnieli E
J Clin Endocrinol Metab; 1986 Dec; 63(6):1411-3. PubMed ID: 3023422
[TBL] [Abstract][Full Text] [Related]
14. Quantitative study of insulin secretion and clearance in normal and obese subjects.
Polonsky KS; Given BD; Hirsch L; Shapiro ET; Tillil H; Beebe C; Galloway JA; Frank BH; Karrison T; Van Cauter E
J Clin Invest; 1988 Feb; 81(2):435-41. PubMed ID: 3276729
[TBL] [Abstract][Full Text] [Related]
15. Insulin, C-peptide and glucagon levels during OGTT in hepatic cirrhosis and in patients with prehepatic block.
Gerö L; Korányi L; Szalay F; Büki B; Tamás G
Acta Diabetol Lat; 1982; 19(1):55-64. PubMed ID: 7041501
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of hyperinsulinaemia in Child's disease grade B liver cirrhosis investigated in free living conditions.
Greco AV; Mingrone G; Mari A; Capristo E; Manco M; Gasbarrini G
Gut; 2002 Dec; 51(6):870-5. PubMed ID: 12427792
[TBL] [Abstract][Full Text] [Related]
17. Resistance to insulin suppression of plasma free fatty acids in liver cirrhosis.
Merli M; Leonetti F; Riggio O; Giaccari A; Romiti A; Sbraccia P; Tamburrano G
J Endocrinol Invest; 1990 Nov; 13(10):787-95. PubMed ID: 2096155
[TBL] [Abstract][Full Text] [Related]
18. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects.
Pagano G; Cavallo-Perin P; Cassader M; Bruno A; Ozzello A; Masciola P; Dall'omo AM; Imbimbo B
J Clin Invest; 1983 Nov; 72(5):1814-20. PubMed ID: 6355186
[TBL] [Abstract][Full Text] [Related]
19. Insulin and glucagon secretion are suppressed equally during both hyper- and euglycemia by moderate hyperinsulinemia in patients with diabetes mellitus.
Murayama Y; Kawai K; Watanabe Y; Yoshikawa H; Yamashita K
J Clin Endocrinol Metab; 1989 May; 68(5):925-31. PubMed ID: 2654170
[TBL] [Abstract][Full Text] [Related]
20. In vivo insulin action in hepatocellular and cholestatic liver cirrhosis.
Barzilai N; Cohen P; Karnieli E; Enat R; Epstein O; Owen J; McIntyre N
J Endocrinol Invest; 1991 Oct; 14(9):727-35. PubMed ID: 1761807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
